Related Experiment Videos
Quinolone generations: natural history or natural selection?
1University of St Andrews, Fife, Scotland, UK. peterball1@aol.com
The Journal of Antimicrobial Chemotherapy
|September 21, 2000
Summary
Quinolone antibiotics have advanced significantly, offering broader antimicrobial activity and improved safety. Gemifloxacin, a third-generation fluoroquinolone, shows promising enhanced gram-positive efficacy and tolerability.
Area of Science:
- Pharmacology
- Microbiology
- Medicinal Chemistry
Background:
- Quinolones evolved from narrow-spectrum antibacterials to broad-spectrum oral and intravenous antibiotics.
- Advancements in structure led to improved activity, pharmacokinetics, and tolerability.
- This evolution expanded indications for various bacterial infections across tissues and fluids.
Purpose of the Study:
- To review the generational progress of quinolone antibiotics.
- To highlight the development of third-generation agents.
- To introduce gemifloxacin as a promising new fluoroquinolone.
Main Methods:
- Literature review of quinolone development.
- Analysis of structural modifications and their impact.
- Evaluation of antimicrobial activity, pharmacokinetics, and tolerability data.
Main Results:
- Quinolones progressed through distinct generations with enhanced properties.
- Third-generation quinolones (IIIa and IIIb) demonstrate significant improvements.
- Gemifloxacin exhibits superior in vitro gram-positive activity and favorable tolerability.
Conclusions:
- Gemifloxacin represents a significant advancement in the fluoroquinolone class.
- Its enhanced gram-positive activity and safety profile are noteworthy.
- Further clinical data will confirm gemifloxacin's therapeutic value.